Welcome back to the Daily Aviation, today we take a closer look at the innovative ways in which US Forces deal with the drone ...

Mary Alice Glen was 37 years old when she was diagnosed with breast cancer in 1996. Years earlier, her mother died from ...

Chimeric antigen receptor, or CAR, therapy is no longer just a cancer story. This review shows how the field is expanding beyond conventional CAR-T cells into a wider family of engineered cell ...

India’s cancer crisis is driven by late detection, with most cases diagnosed late. Improving awareness, screening, and timely ...

Three posters accepted at AACR 2026 highlighting SK Life Science Labs' targeted protein degradation pipeline -- Programs featured: selective p300 and PRMT5 degraders -- p300 degrader data demonstrate: ...

Los Angeles–based cancer researcher Flavia Pichiorri urges a shift toward clinically driven research to improve outcomes in ...

Multiple myeloma research led by researchers at the University of Calgary identified how tumor cells adapt after ...

That fourth drug is Pomalyst, a treatment from Bristol Myers Squibb for multiple myeloma. That’s a relatively uncommon cancer ...

CEM breast cancer imaging shows strong agreement with MRI and histopathology for tumour size and disease extent. Learn more.

Dana-Farber Cancer Institute researchers will present more than 50 studies at the American Association for Cancer Research ...

Dr. Sigurdur Y. Kristinsson, the Principal Investigator of iStopMM at the University of Iceland, will present to participants about IMF-led research in Iceland. Then, cyclists will take a tour of the ...

Dr. Costa addresses community-based versus academic center care debates for complex patients requiring multiple therapy lines ...